302 related articles for article (PubMed ID: 23547842)
1. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors.
Wei X; Senanayake TH; Warren G; Vinogradov SV
Bioconjug Chem; 2013 Apr; 24(4):658-68. PubMed ID: 23547842
[TBL] [Abstract][Full Text] [Related]
2. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.
Wei X; Senanayake TH; Bohling A; Vinogradov SV
Mol Pharm; 2014 Sep; 11(9):3112-22. PubMed ID: 25072100
[TBL] [Abstract][Full Text] [Related]
3. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
Liang K; Ng S; Lee F; Lim J; Chung JE; Lee SS; Kurisawa M
Acta Biomater; 2016 Mar; 33():142-52. PubMed ID: 26785145
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-fullerene/AIEgen nanogel as CD44-targeted delivery of tirapazamine for synergistic photodynamic-hypoxia activated therapy.
Hong X; Xu X; Liu Z; Liu S; Yu J; Wu M; Ma Y; Shuai Q
Nanotechnology; 2021 Aug; 32(46):. PubMed ID: 34325415
[TBL] [Abstract][Full Text] [Related]
5. Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against HeLa cells.
Li F; Bae BC; Na K
Bioconjug Chem; 2010 Jul; 21(7):1312-20. PubMed ID: 20586473
[TBL] [Abstract][Full Text] [Related]
6. Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors.
Yang C; Li C; Zhang P; Wu W; Jiang X
Theranostics; 2017; 7(6):1719-1734. PubMed ID: 28529647
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid and hyaluronic acid: Sucrose nanogels for hydrophobic cancer drug delivery.
Sagbas Suner S; Ari B; Onder FC; Ozpolat B; Ay M; Sahiner N
Int J Biol Macromol; 2019 Apr; 126():1150-1157. PubMed ID: 30625351
[TBL] [Abstract][Full Text] [Related]
8. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.
Wang J; Li Y; Wang L; Wang X; Tu P
Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064
[TBL] [Abstract][Full Text] [Related]
9. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery.
Hang C; Zou Y; Zhong Y; Zhong Z; Meng F
Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090
[TBL] [Abstract][Full Text] [Related]
10. Comparison of nanogel drug carriers and their formulations with nucleoside 5'-triphosphates.
Vinogradov SV; Kohli E; Zeman AD
Pharm Res; 2006 May; 23(5):920-30. PubMed ID: 16715382
[TBL] [Abstract][Full Text] [Related]
11. Thermoresponsive hyaluronic acid nanogels as hydrophobic drug carrier to macrophages.
Fernandes Stefanello T; Szarpak-Jankowska A; Appaix F; Louage B; Hamard L; De Geest BG; van der Sanden B; Nakamura CV; Auzély-Velty R
Acta Biomater; 2014 Nov; 10(11):4750-4758. PubMed ID: 25110287
[TBL] [Abstract][Full Text] [Related]
12. pH-Responsive Fluorescence Enhanced Nanogel for Targeted Delivery of AUR and CDDP Against Breast Cancer.
Cao Z; Li W; Liu R; Li C; Song Y; Liu G; Chen Y; Lu C; Lu A; Liu Y
Int J Nanomedicine; 2020; 15():8369-8382. PubMed ID: 33149581
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation and pH-responsive release of bortezomib by dopamine grafted hyaluronate nanogels.
Liu L; Luan S; Zhang C; Wang R; Zhang Y; Zhang M; Sheng Q; Han G; Wang T; Song S
Int J Biol Macromol; 2021 Jul; 183():369-378. PubMed ID: 33932413
[TBL] [Abstract][Full Text] [Related]
14. pH-Sensitive Coiled-Coil Peptide-Cross-Linked Hyaluronic Acid Nanogels: Synthesis and Targeted Intracellular Protein Delivery to CD44 Positive Cancer Cells.
Ding L; Jiang Y; Zhang J; Klok HA; Zhong Z
Biomacromolecules; 2018 Feb; 19(2):555-562. PubMed ID: 29284258
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid hydrogels with defined crosslink density for the efficient enrichment of breast cancer stem cells.
Tan S; Yamashita A; Gao SJ; Kurisawa M
Acta Biomater; 2019 Aug; 94():320-329. PubMed ID: 31125725
[TBL] [Abstract][Full Text] [Related]
16. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
[TBL] [Abstract][Full Text] [Related]
18. CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation.
Seok HY; Sanoj Rejinold N; Lekshmi KM; Cherukula K; Park IK; Kim YC
J Control Release; 2018 Jun; 280():20-30. PubMed ID: 29723613
[TBL] [Abstract][Full Text] [Related]
19. Application of activated nucleoside analogs for the treatment of drug-resistant tumors by oral delivery of nanogel-drug conjugates.
Senanayake TH; Warren G; Wei X; Vinogradov SV
J Control Release; 2013 Apr; 167(2):200-9. PubMed ID: 23385032
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid/poly(β-amino ester) polymer nanogels for cancer-cell-specific NIR fluorescence switch.
Park HS; Lee JE; Cho MY; Hong JH; Cho SH; Lim YT
Macromol Rapid Commun; 2012 Sep; 33(18):1549-55. PubMed ID: 22753358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
